Dublin, March 13, 2026 (GLOBE NEWSWIRE) -- The "Spherusol Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering.
The historic growth of the Spherusol market is largely due to improved understanding of coccidioidomycosis epidemiology, serological diagnostics, expansion of public health screening, and innovations in fungal pathogenesis research. The forecast period indicates growth through enhanced investment in infectious disease surveillance, demand for early detection tools, and increased testing in endemic regions. Trends include advanced skin tests, focus on immune response detection, and expanded fungal infection surveillance.
Notably, the rising incidence of coccidioidomycosis (Valley fever) is a key driver for Spherusol's market growth. Caused by the Coccidioides fungus, this infection thrives in arid conditions and primarily affects respiratory systems. Warmer climates and population growth in vulnerable areas increase exposure risk. Spherusol aids diagnosis by detecting hypersensitivity to Coccidioides immitis with a skin test. California's report showed over 5,500 provisional cases in 2025's first half, following 12,500 cases in 2024, signaling a persistent upward trend.
An aging population also boosts the Spherusol market. As healthcare advancements extend life expectancy, the senior demographic (65+) grows, heightening vulnerability to immune-related issues. Spherusol helps manage immune responses in this group, improving diagnostic accuracy and preventive care. The Population Reference Bureau noted a projected rise of Americans aged 65+ from 58 million in 2022 to 82 million by 2050, increasing their population share from 17% to 23%.
The increase in outdoor activities further propels Spherusol demand. Exposure to environmental pathogens necessitates immune monitoring, which Spherusol supports by detecting hypersensitivity responses. According to the Outdoor Industry Association, 175.8 million participated in outdoor recreation in 2023, marking a 4.1% increase.
Leading company in the Spherusol market includes Nielsen Biosciences Inc. North America remains dominant, with expectations of rapid growth during the forecast period. The spherusol market's geographical coverage spans Asia-Pacific, Western and Eastern Europe, North and South America, and others.
Reasons to Purchase:
- Attain a global perspective with an exhaustive report covering 16 geographies.
- Evaluate the influence of macro factors such as geopolitical tensions, trade policies, and regulatory developments.
- Develop regional and country-specific strategies based on localized data and analysis.
- Identify lucrative growth segments for potential investments.
- Gain a competitive edge using forecast data, key market drivers, and prevalent trends.
- Understand target customers through end-user analysis.
- Benchmark against competitors based on market share, innovation, and brand strength.
- Analyze total addressable market (TAM) and market attractiveness to assess potential.
- Support internal and external presentations with robust data and analysis.
- Receive updates with the latest data and an Excel dashboard for seamless data extraction and analysis.
For more information about this report visit https://www.researchandmarkets.com/r/4i40he
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
